White Rose University Consortium logo
University of Leeds logo University of Sheffield logo York University logo

Quantitative Assessment of the outcome of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Macular Degeneration

Gale, Richard (2015) Quantitative Assessment of the outcome of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Macular Degeneration. PhD thesis, University of York.

Final_re uploaded version_17112015.pdf
Available under License Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 UK: England & Wales.

Download (2058Kb) | Preview


Neovascular Macular Degeneration is a significant cause of blindness world–wide. Anti-Vascular Endothelial Growth Factor medication injected directly into the eye has halved the disease burden in recent years. Being able to adequately quantify the outcome of neovascular AMD treatment gives perspective not only on appropriate intervention for individual patients, but also the understanding of the science behind the disease, its therapeutics and design of future clinical trials. Assessment tools can be either subjective or objective, and often interrogate either efficacy or safety endpoints. Although patient reported Quality of Life utilities give the ultimate assessment of treatment success for an individual, surrogate biomarkers are more effective in judging short-term response. Visual acuity assessment is useful in analyzing cohorts of individuals, but its subjective nature means that it is not particularly useful in determining individual retreatment decisions. An objective morphological assessment of the macular architecture does provide a good way of assessing short-term response however. Retinal sensitivity also demonstrates usefulness as an endpoint for clinical trials, but as of yet is too cumbersome a technique for high volume clinical work. Functional imaging of the visual cortex remains a research tool at present, but provides promise as a new objective endpoint. Importantly this thesis has confirmed that that cortex is able to regain function after a short period of compromise due to neovascular macular degeneration. Measurement tools to assess the outcome of treatment are best selected, often in composite, with regards to the prime reason for assessment being undertaken.

Item Type: Thesis (PhD)
Keywords: Macular Degeneration, Treatment, Vascular Endothelial Growth Factor, Visual acuity, Optical Coherence Topography, Quality of Life, Patient Recorded outcome Measures, Microperimetry, Retinal sensitivity, Functional Magnetic Resonance Imaging, Blood oxygen level dependent
Academic Units: The University of York > Psychology (York)
Identification Number/EthosID: uk.bl.ethos.675097
Depositing User: Mr Richard Gale
Date Deposited: 09 Dec 2015 16:07
Last Modified: 08 Sep 2016 13:33
URI: http://etheses.whiterose.ac.uk/id/eprint/11140

You do not need to contact us to get a copy of this thesis. Please use the 'Download' link(s) above to get a copy.
You can contact us about this thesis. If you need to make a general enquiry, please see the Contact us page.

Actions (repository staff only: login required)